Pfizer (PFE) shares decline 3% following CFO Dave Denton's departure announcement.

{
  "signal_id": "de7540bb-8f8d-40c6-8ab5-7372b5097e6b",
  "signal_type": "news",
  "signal_subtype": "leaves",
  "detected_at": "2026-06-18T15:35:54+00:00",
  "company": {
    "name": "Pfizer",
    "domain": "pfizer.com"
  },
  "data": {
    "url": "https://moneycheck.com/pfizer-pfe-shares-decline-3-following-cfo-dave-dentons-departure-announcement",
    "title": "Pfizer (PFE) shares decline 3% following CFO Dave Denton's departure announcement.",
    "ticker": "NYSE:PFE",
    "contact": "Dave Denton",
    "excerpt": "Pfizer (PFE) shares decline 3% following CFO Dave Denton's departure announcement.\n\nKey points.\n\nTable of Contents\n\n* Dave Denton, Pfizer's Chief Financial Officer, will depart the pharmaceutical giant on August 15 to pursue opportunities in consumer goods\n* Shares of PFE declined approximately 3%, reaching $25.10 in morning trading\n* Veteran finance executive Cecile Guegan appointed to interim CFO position; she brings over two decades of Pfizer finance experience\n* Concerns raised by Scotiabank regarding 2026 projections, leadership continuity, and competitive positioning in obesity therapeutics\n* Both internal candidates and external prospects will be considered for the permanent CFO position\n\nShares of Pfizer (PFE) experienced a roughly 3% decline Thursday following the pharmaceutical company's revelation that Chief Financial Officer Dave Denton plans to resign effective August 15, with shares hovering around $25.10 during early market activity.\n\nDenton's decision to depart stems from his desire to return to the consumer goods sector, concluding a four-year chapter with the pharmaceutical manufacturer. His arrival at Pfizer in 2022 followed an extensive career that included serving as CFO at CVS Health for approximately two decades and a subsequent position at Lowe's.\n\nCecile Guegan will assume the interim CFO responsibilities. Currently holding the position of senior vice...",
    "summary": "Dave Denton will leave Pfizer Inc as Chief Financial Officer on Aug 15th '26.",
    "planning": false,
    "image_url": "https://moneycheck.com/wp-content/uploads/2026/06/Pfizer-1-scaled-1.jpg",
    "job_title": "Chief Financial Officer",
    "confidence": 0.835,
    "published_at": "2026-06-18T15:35:54Z",
    "effective_date": "2026-08-15",
    "job_title_tags": [
      "finance"
    ],
    "article_sentence": "* Dave Denton, Pfizer's Chief Financial Officer, will depart the pharmaceutical giant on August 15 to pursue opportunities in consumer goods"
  }
}

curl https://signals.autobound.ai/v1/signals/de7540bb-8f8d-40c6-8ab5-7372b5097e6b \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"pfizer.com","limit":20}'